SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SB-2/A - Optional form for registration of securities to be sold to the public by small business issuers: [Amend]
SEC Accession No. 0001144204-05-020599
Filing Date
2005-07-01
Accepted
2005-07-01 17:17:57
Documents
6

Document Format Files

Seq Description Document Type Size
1 v020980_sb2a.htm SB-2/A 2261583
2 v020980_ex5-1.htm EX-5.1 9069
3 v020980_ex10-27.htm EX-10.27 22439
4 v020980_ex23-1.htm EX-23.1 3672
5 v020980_ex23-2.htm EX-23.2 4354
6 filename6.htm CORRESP 41880
  Complete submission text file 0001144204-05-020599.txt   2344579
Mailing Address 5511 CAPITAL CENTER DRIVE SUITE 224 RALEIGH NC 27606
Business Address 5511 CAPITAL CENTER DRIVE SUITE 224 RALEIGH NC 27606 919-852-4482
Grant Life Sciences, Inc. (Filer) CIK: 0001210336 (see all company filings)

IRS No.: 820490737 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SB-2/A | Act: 33 | File No.: 333-119425 | Film No.: 05934113
SIC: 2835 In Vitro & In Vivo Diagnostic Substances